Clinical Trials Containment Genetic Analysis Genetics 
The Pharma Data
SEPTEMBER 3, 2020
The research, published in the journal Gut, revealed that 83% of aggressive, metastatic-like tumours contained particularly high levels of a gene called TLR3, part of a damage-alert system that mimics the infection response triggered by viruses, drawing immune cells to the tumour. Source link.
The Pharma Data
APRIL 8, 2022
Data from the research were recently included in the company’s Investigational New Drug (IND) application to the FDA to initiate a Phase 2 clinical trial for COVID-19. Based on these studies, one of those drugs was licensed to Cantex Pharmaceuticals for the treatment of COVID-19 and other inflammatory lung diseases.
Drug Discovery World
JUNE 14, 2023
It enables development and production of Advanced Therapies by providing access to human cells and tissue, testing services and biomanufacturing and clinical trials support.
Expert insights. Personalized for you.
52 
Let's personalize your content